Protamine-reactive igm antibodies
CA 1340982 C · Owner: Rodman, Toby C. · Inventors: Rodman, Toby C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to protamine-reactive IgM antibodies, and their uses in prognosis diagnosis, and therapy. In a specific embodiment the invention relates to, low affinity binding protamine-reactive serum IgM antibodies. In particular such antibodies can recognize a sequence comprising four arginyl residues, including a triplet within a, six amino acid residue sequence. Such antibodies may be natural antibodies (i.e. not induced). A low affinity subset of serum protamine-reactive IgM antibodies may be assayed for prognosis or diagnosis of AIDS. Such antibodies are detectable in sera of normal subjects and HIV-infected individuals who subsequently exhibit a significant period …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted May 2, 2000. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended May 2, 2017.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.